OrganoClick AB (ORGC) AI Stock Analysis

• Market Cap: €195.81M
• Dividend Yield: N/A
• Average Volume (3M): 87.89K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.05
• Revenue Growth: -18.29%
• EPS Growth: -48.74%
• Country: SE
• Employees: 40
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): -0.08
• Shares Outstanding: 110,003,010
• 10 Day Avg. Volume: 18,569
• 30 Day Avg. Volume: 87,893
• PEG Ratio: -1.25
• Price to Book (P/B): 9.71
• Price to Sales (P/S): 2.21
• P/FCF Ratio: -51.08
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: kr1.50 ▼(-16.67% Downside)

OrganoClick AB's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenue, high leverage, and weak cash flow management. Technical analysis indicates a lack of strong momentum, and valuation metrics are unattractive due to ongoing losses. The absence of earnings call data and corporate events did not influence the score.

Positive Factors

Sustainable Product Focus

OrganoClick's focus on environmentally friendly products positions it well in the growing market for sustainable solutions, providing a competitive edge and potential for long-term growth as industries increasingly prioritize sustainability.

Innovative Product Offerings

The company's innovative product range supports its mission to replace traditional materials with sustainable alternatives, potentially driving demand across various sectors and enhancing its market position.

Partnerships and Collaborations

Strategic partnerships and collaborations enable OrganoClick to expand its market reach and leverage shared expertise, fostering innovation and potentially leading to increased revenue streams through collaborative projects.

Negative Factors

Declining Revenue

The decline in revenue growth indicates challenges in maintaining sales momentum, which could impact long-term financial health and necessitate strategic adjustments to reverse this trend.

High Leverage

High leverage suggests significant reliance on debt financing, which can strain financial flexibility and increase risk, especially if revenue and profitability do not improve.

Weak Cash Flow

Weak cash flow generation raises concerns about OrganoClick's ability to sustain operations without external financing, potentially limiting its ability to invest in growth opportunities.

OrganoClick AB Business Overview & Revenue Model

Company Description

OrganoClick AB (ORGC) is a Swedish company that specializes in sustainable textile and material solutions, focusing on environmentally friendly products and processes. The company operates in sectors such as textiles, coatings, and biocomposites, offering a range of innovative products including biodegradable textiles, functional coatings, and environmentally friendly alternatives to traditional synthetic materials. OrganoClick's mission is to promote sustainability in various industries by providing high-performance materials derived from renewable resources.

How the Company Makes Money

OrganoClick generates revenue primarily through the sale of its sustainable products to various industries, including textiles, construction, and packaging. The company has several key revenue streams, including direct sales of its innovative textile solutions, functional coatings, and biocomposite materials. Additionally, OrganoClick engages in partnerships with manufacturers and brands seeking to incorporate sustainable materials into their products, which can lead to collaborative projects and licensing agreements. The company's focus on research and development also allows it to stay competitive and expand its product offerings, contributing to its overall earnings.

OrganoClick AB Financial Statement Overview

Summary

OrganoClick AB faces significant financial challenges across all verticals. The company struggles with declining revenues, persistent losses, high leverage, and weak cash flow generation. These factors collectively indicate financial instability and potential risks, necessitating strategic interventions to improve operational efficiency and financial health.

Income Statement

OrganoClick AB's income statement reveals significant challenges. The company has experienced declining revenue growth, with a negative growth rate of -7.06% in the TTM period. Profitability metrics are concerning, with negative net profit and EBIT margins, indicating ongoing operational losses. The gross profit margin has decreased over time, reflecting potential pricing pressures or cost inefficiencies.

Balance Sheet

The balance sheet shows high leverage, with a debt-to-equity ratio of 3.82 in the TTM period, indicating significant reliance on debt financing. The return on equity is negative, reflecting the company's inability to generate profits from shareholders' equity. The equity ratio is relatively low, suggesting limited financial stability.

Cash Flow

Cash flow analysis highlights liquidity issues, with negative free cash flow and a low operating cash flow to net income ratio. Although there is some improvement in free cash flow growth, the overall cash flow position remains weak, raising concerns about the company's ability to sustain operations without external financing.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	109.25M	127.23M	145.87M	115.05M	110.06M	96.46M
Gross Profit	22.06M	31.84M	35.39M	12.94M	18.51M	20.20M
EBITDA	-3.99M	5.71M	5.95M	-21.19M	-12.92M	-4.41M
Net Income	-26.35M	-17.97M	-15.77M	-41.62M	-31.03M	-19.52M
Balance Sheet
Total Assets	157.77M	126.98M	150.75M	162.86M	188.39M	152.80M
Cash, Cash Equivalents and Short-Term Investments	5.34M	538.00K	10.74M	15.20M	34.25M	32.03M
Total Debt	74.86M	51.67M	62.39M	61.68M	53.54M	43.36M
Total Liabilities	117.57M	89.15M	97.34M	95.30M	80.66M	69.86M
Stockholders Equity	33.15M	28.98M	44.58M	58.78M	100.33M	54.08M
Cash Flow
Free Cash Flow	-17.27M	-5.51M	-8.08M	-35.35M	-52.34M	-13.93M
Operating Cash Flow	-6.55M	3.60M	533.00K	-21.22M	-37.69M	5.47M
Investing Cash Flow	-10.71M	-9.11M	-8.61M	-7.45M	-14.65M	-19.40M
Financing Cash Flow	18.27M	-4.69M	3.60M	9.63M	54.56M	-15.19M

OrganoClick AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.80
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ORGC, the sentiment is Positive. The current price of 1.8 is above the 20-day moving average (MA) of 1.70, above the 50-day MA of 1.72, and below the 200-day MA of 1.96, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.20 is Neutral, neither overbought nor oversold. The STOCH value of 65.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:ORGC.

OrganoClick AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
POLYG	52 Neutral	€365.27M	-24.18	-5.04%	2.87%	7.92%	94.99%
ORGC	45 Neutral	€195.81M	-7.67	-75.16%	―	-18.29%	-48.74%
NEXAM	45 Neutral	€254.88M	-17.80	-7.96%	―	-1.89%	-59.17%